Association of raltegravir use with long-term health outcomes in HIV-infected patients: an observational post-licensure safety study in a large integrated healthcare system.
Michael A HorbergAllison H OakesLeo B HurleyWilliam J TownerChun R ChaoMichael J SilverbergJean Q ChantraCourtney G EllisCharles P QuesenberryPublished in: HIV clinical trials (2018)
The potentially elevated risk for malignancy and mortality with raltegravir and residual confounding merits further investigation. We demonstrate the value of observational cohorts for monitoring post-licensure medication safety.